The cost of not re-testing: HIV misdiagnosis in the ART ‘test-and-offer’ era
Article published in Clinical Infectious Diseases - April 2017
We compared estimated costs of re-testing HIV-positive persons before ART initiation to the costs of ART provision to misdiagnosed HIV-negative persons.
Savings from averted unnecessary ART costs were greater than re-testing costs within one year using assumptions representative of HIV testing performance in programmatic settings.
Countries should implement re-testing before ART initiation.